142
Views
7
CrossRef citations to date
0
Altmetric
Review

The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting

, , , ORCID Icon, , , ORCID Icon & show all
Pages 7747-7757 | Published online: 09 Oct 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.